Overall rank by patents
#26,684
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 19 technology areas, active 2015–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).
The verdict
Kabushiki holds 10 US patents across 19 technology areas, rank #26,684 of 50,000 tracked assignees.
Kabushiki Kaisha Sangi has been granted 10 US utility patents between 2015 and 2021, placing Kabushiki Kaisha Sangi at rank #26,684 across all assignees tracked by PlainPatent. This portfolio spans 19 distinct Cooperative Patent Classification (CPC) subclasses, averaging 10.5 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Kabushiki Kaisha Sangi is one of the more focused assignees in the PatentsView dataset. By volume, Kabushiki sits between KSM Component Co., Ltd. (10 patents, rank #26,680) and Kerdea Technologies, Inc. (10 patents, rank #26,688) - the closest US assignees by grant volume. The composite Innovation Score of 30.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 1 grants, compared with 9 in the 2015–2019 window, a -89% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Kabushiki Kaisha Sangi's 10.5 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while concentration in 19 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Kabushiki Kaisha Sangi against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
KSM COMPONENT CO., LTD.
10 patents
KYOCERA MEDICAL CORPORATION
10 patents
KYOCERA SGS PRECISION TOOLS, INC.
10 patents
KYUSHU ELECTRIC POWER CO., INC.
10 patents
Kaneya Co., Ltd.
10 patents
Kashiv Specialty Pharmaceuticals, LLC
10 patents
Katco Holdings Pty Ltd
10 patents
Kerdea Technologies, Inc.
10 patents
Kabushiki Kaisha Sangi
10 patents
What this shows Kabushiki holds 10 patents at rank #26,684, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Kabushiki's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
30 Top 67% higher than 33% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 30.0% |
| 2016 | 3 | 30.0% |
| 2017 | 1 | 10.0% |
| 2018 | 2 | 20.0% |
| 2021 | 1 | 10.0% |
Top 15 of 19 technology areas
Overall rank by patents
#26,684
Across all tracked assignees
30.0 out of 100
How to use this portfolio
Kabushiki's 10 grants land it in the top 67% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.